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Abstract.  Quiescent smooth muscle cells (SMC) in 
normal artery express a  pattern of actin isoforms with 
a-smooth muscle (ctSM) predominance that switches 
to 13 predominance when the cells are proliferating. 
We have examined the relationship between the change 
in actin isoforms and entry of SMC into the growth 
cycle in an in vivo model of SMC proliferation (bal- 
loon injured rat carotid artery),  aSM actin mRNA 
declined and cytoplasmic (13  +  ~') actin mRNAs in- 
creased in early G0/G~ (between  1 and 8 h after in- 
jury). In vivo synthesis and in vitro translation experi- 
ments demonstrated that functional aSM mRNA is 
decreased 24 h after injury and is proportional to the 
amount of mRNA present.  At 36 h  after injury, SMC 
prepared by enzymatic digestion were sorted into 
G0/G~ and S/G2 populations; only the SMC committed 
to proliferate (S/G2  fraction) showed a  relative slight 
decrease in ¢tSM  actin and, more importantly, a  large 
decrease in ctSM actin mRNA.  A  switch from ¢tSM 
predominance to 13 predominance was present in the 
whole SMC population 5 d after injury. To determine 
if the change in actin isoforms was associated with 
proliferation, we inhibited SMC proliferation by 
~80%  with heparin,  which has previously been shown 
to block SMC in late G0/G~ and to reduce the growth 
fraction. The switch in actin mRNAs and synthesis at 
24 h  was not prevented; however, ctSM mRNA and 
protein were reinduced at 5 d  in the heparin-treated 
animals compared to saline-treated controls. These 
results suggest that in vivo the synthesis of actin iso- 
forms in arterial SMC depends on the mRNA levels 
and changes after injury in early G0/Gt  whether or not 
the cells subsequently proliferate. The early changes in 
actin isoforms are not prevented by heparin, but they 
are eventually reversed if the SMC are kept in the 
resting state by the heparin treatment. 
TIr~ exists in six different, highly conserved isoforms 
that are expressed in unique patterns depending upon 
the type and growth state of the individual cell (35, 
38,  40).  It  is  known  that  arterial  smooth  muscle  cells 
(SMC) l from mature animals express predominantly the or- 
smooth muscle (ctSM) actin isoform (15, 41). This pattern is 
altered to 13 actin predominance when SMC proliferate under 
a variety of normal and pathological conditions as well as in 
culture (1,  14, 20-23,  31, 32,  34, 37-39). 
The relationships between growth state and expression of 
actin  isoforms  in  SMC  is  presently  not  clear.  Although 
proliferating SMC in vivo eventually re-express aSM actin 
as they return to quiescence (22),  cultured SMC growth ar- 
rested by serum starvation show slight re-expression of ctSM 
actin and usually do so only if they are also in a postconfluent 
state (32, 34).  Even so, the expression of ctSM actin is never 
1. Abbreviations used in this paper: 0tSM, a-smooth muscle; SMC, smooth 
muscle cells. 
as great as it is in vivo. Owens et al. (32) have reported that 
after  the  addition  of serum  to  passaged  growth-arrested 
SMC, ctSM actin synthesis declines before the cells enter S 
phase; Skalli et al. (34) observed that among primary cul- 
tured SMC entering the growth cycle for the first time, only 
those in S phase show a decrease in ctSM actin. 
To examine the regulation of actin isoform expression in 
arterial SMC stimulated to enter the growth cycle, we have 
made use of an in vivo model of SMC mitogenesis. In the 
adult  rat  carotid,  SMC  proliferation is  barely  detectable 
(0.06%  per day; 9); between 24 and 27 h after endothelial 
removal  by the passage of an inflated intraluminal balloon 
catheter, '~30% of the cells enter S phase as a synchronous 
wave (7,  8, 27). 
We now demonstrate that changes in actin isoform mRNA 
level and synthesis occur long before SMC enter S phase and 
can be dissociated from entry into S phase with the growth 
inhibitor heparin. In the absence of heparin, changes in actin 
isoform mRNA level and expression are mostly seen in SMC 
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Go or G~.  Furthermore, arteries in which SMC prolifera- 
tion is partially inhibited by heparin exhibit re-expression of 
the differentiated phenotype as early as 5 d after injury. 
Materials and Methods 
SMC Mitogenesis in Vivo 
SMC were induced to proliferate in the left carotid arteries of male Wistar 
rats (between 400 and 500 g) by denuding the endothelium and stretching 
the wall with a balloon catheter (9).  In this arterial injury model, there is 
also some loss of SMC from the inner layer of  the media (9). For the experi- 
ments involving protein, DNA, or RNA extraction, injured left carotids and 
uninjured right carotids were removed at various times after surgery, flushed 
with saline solution, stripped of adventitia and frozen in liquid nitrogen. 
SMC proliferation was inhibited by the administration of heparin (6-8, 
27).  Subcutaneous miniosmotic pumps (model 2ML2;  Alza Corp.,  Palo 
Alto, CA) connected to indwelling left  jugular venous catheters were placed 
either 24 h before or  just after carotid injury; heparin (type II; Sigma Chem- 
ical Co., St. Louis, MO) was delivered continuously and intravenously at 
the rate of  0.3 mg/kg/per h. Control animals received a continuous infusion 
of the carrier solution (normal saline). 
Cell Sorting 
Populations of quiescent (Go/G~) or proliferating (S/G2)  SMC  were ob- 
tained by enzymatic digestion of injured carotids and cell sorting of the 
SMC at 36 h after surgery. At this time, cells committed to enter the cycle 
(20-30% of the SMC) are in S or G2 phases but have not divided (27); as 
well, very few of the remaining G0/G~ cells (70-80% of the SMC) subse- 
quently proliferate (7, 8). For each experiment, 10 injured carotids were ex- 
cised, irrigated clear of blood, stripped of adventitia, and minced. The tis- 
sue was digested in medium containing collagenase and elastase for ",,2 h 
at 37°C as described previously (34). FCS (final concentration 20%) was 
added and the solution filtered through nylon mesh. The isolated cells were 
centrifuged at 200  g,  resuspended in PBS containing  1%  albumin,  and 
stained with Hoechst dye for 20 min. Less than 5 % of  the cells were stained 
positive with trypan blue.  The cells were again pelleted, resuspended in 
PBS, and sorted into G0/G~ or S/G2 populations (34).  The isolated cells 
were pelleted, resuspended in 50 ~1 of sample buffer, and stored at -20°C 
for try-dimensional gel analysis. 
SMC Proliferation 
To  quantitate  SMC  proliferation,  animals  received  [3H]thymidine  (5.0 
Ci/mM; Amersham Corp., Ziirich, Switzerland), 0.5 mCi/kg i.p. at 17, 9, 
and 1 h before they were killed; carotids from these animals were fixed by 
perfusion in 4%  paraformaldehyde in  PBS,  embedded in paraffin,  sec- 
tioned,  and processed as  described previously  for autoradiography  (9). 
Slides dipped in emulsion (NTB2;  Eastman Kodak Co., Rochester, NY) 
were developed after 2 wk and the fraction of labeled nuclei determined. 
RNA Extraction 
Frozen carotid arteries were pooled (10-15 carotids per time point) and rap- 
idly homogenized with a polytron (type PT  10/35;  Kinematica, Lucerne, 
Switzerland) for 60 s in 3.5 ml of a sterile solution, pH 7.4, containing 4.5 
M guanidinium thiocyanate, 50 mM EDTA,  25 mM sodium citrate, 0.1 M 
2-[3-mercaptoethanol, and 2% laurylsarcosine. The preparations were fur- 
ther  homogenized  with  a  syringe  attached  to  a  21-gauge  needle.  The 
homogenates were centrifuged for 10 min at 5,900 g at 15°C and the super- 
natant further purified by ultracentrifugation through a cushion of 5.7 M 
CsCl  as  described  by  Chirgwin  et  al.  (5).  The  RNA  pellets  were 
resuspended in 10 mM Tris-HCl, pH 7.4,  0.5%  SDS, and 1 mM EDTA, 
extracted twice with saturated phenol-chloroform, and then extracted once 
with  chloroform-isoamylalcohol (24:1;  vol/vol).  The  RNA  was  ethanol 
precipitated, resuspended in sterile water,  and stored at  -70°C. 
RNA from cytofluorometrically isolated SMC was purified as follows: 
SMC were suspended in PBS (2  x  106 cells/ml); 8  x  104 cells (40  p.I) 
were lyzed in 0.1  M  Tris-HCl buffer,  pH 7.4,  containing 360  I.tl of 4  M 
guanidine thiocyanate and 1 M [3-mercaptoethanol.  After addition of 20 p.g 
of randomized Escherichia coli RNA as carrier,  the nucleic acids were 
precipitated in ethanol and purified as described by Huarte et al.  (18). 
Figure 1.  Two-dimensional gel electrophoresis of total protein ex- 
tracts from injured rat carotids at 0  h (a), 8 h (b), 24 h  (c), 5 d  (d), 
and 5  d  heparin-treated (e).  Only the actin isoforms (tx,  [3, y) are 
shown. Note the decrease in ct and increase in 13 at 5 d and the rever- 
sal  in the heparin-treated vessel. 
Northern Blot Hybridization 
Total RNAs (2 p.g/lane) were denatured with glyoxal and were subjected to 
electrophoresis in 1% agarose gels in 10 mM phosphate buffer, pH 6.8; gels 
were stained with acridine orange and examined under UV light. The RNAs 
were then transferred to Biodyne filters (Pall Corp., Glen Cove, NY); the 
filters were baked for 2 h under vacuum at 80°C. The Northern blots were 
prehybridized for 4  h at 58°C in 50%  deionized formamide, 50 mM Na 
Pipes buffer, pH 6.8, 0.8 M NaCI, 2 mM EDTA, 0.1% SDS, 2.5x Denhardt's 
solution (28), and 100 p.g/ml denatured salmon sperm DNA. Hybridization 
was carried out under the same conditions with SP6-RNA polymerase-tran- 
scribed 32p-labeled  cRNA probes according to  Melton et al.  (29).  The 
probes used were derived either from the coding region (total  actin probe 
[pRAoo.A-C]:  a  320-bp Bgl  II-Ava II fragment corresponding to the se- 
quence coding for the amino acids 185-291)  or from the 3' untranslated re- 
gion of the aSM actin mRNA (¢tSM probe [pRAooA-3'UT]: a 130-bp Dde 
I-Hind III fragment; 21). The Northern blots were washed twice for 20 min 
at 58°C in 3x SSC and 2x Denhardt's solution, and subsequently in 0.2x 
SSC, 0.1% SDS, and 0.1% Na-pyrophosphate, pH 7.0, for 20 min at the same 
temperature for the total actin probe or for three washes 20 min each at 78°C 
for the ¢tSM  actin probe.  The filters were dried and exposed to Kodak 
X-Omat SO-282 film at  -70°C between intensifying screens. Films were 
exposed between 1 and 3 d and analyzed by means of computerized densito- 
metric scanning. We have previously shown that there is a good correlation 
between densitometry and scintillation counting (1, 20).  The fractions of 
¢tSM and [~ actin +  ~, actin mRNAs as a percentage of total  actin mRNA 
were obtained by calculating the ratio between the 1.7- or 2.1-kb band and 
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Carotid Artery 
Actin isoforms 
Time after injury  ct  13  ~, 
Normal  artery  81.2  +  1.0  13.9  +  0.8  4.9  4- 2.0 
8  h  88.2  +  2.9  9.2  4-  3.2  2.7  4- 0.3 
24 h  79.7  +  1.4  16.7  4-  1.3  3.7  4-  1.7 
5  d  45.0  4-  3.0  39.3  4- 0.7  15.7  +  2.6 
5  d,  saline-treated  44.3  4- 2.5  43.4  +  4.7  12.3  4- 2.5 
5  d,  heparin-treated  65.3  4- 4.9  24.1  4-  8.5  10.7  4-  3.5 
All values are mean (% of total  actin)  _+  SD;  n  =  2. 
the sum of the  1.7- and 2.1-kb  bands on Northern blots hybridized with 
pRAootA-C. The percentage of nSM and of 13 actin +  "y actin mRNAs were 
calculated by arbitrarily defining 100 values of the respective bands of con- 
trol at 0 h  for each experiment. 
In Vitro Translation of Total RNA 
In vitro translation of total rat carotid RNA was conducted according to the 
protocol  of  Pelham  and  Jackson  (33)  using  rabbit  reticulocyte  lysate 
(Genofit,  Geneva,  Switzerland) and  3SS-labeled  methionine (Amersham 
Corp., Ziirich, Switzerland; 1).  The products were analyzed by one- and 
two-dimensional gel electrophoresis. 
Protein Synthesis In Vivo 
Six rats underwent left carotid injury and insertion of Alzet pumps contain- 
ing either heparin or saline as described above. In addition, a percutaneous 
indwelling catheter was placed in the right jugular vein and connected to 
a syringe infusion pump. The animals were left unrestrained. 18 h after sur- 
gery, when the animals were awake and eating, an infusion of [35S]methio- 
nine (3.0 mCi/ml in lactated Ringer's solution; prepared according to the 
method of Crawford and Gesteland [10]) was started and continued for 6 h 
at an infusion rate of 0.8 ml/h (1). At the end of 6 h blood was collected 
in heparinized tubes for determination of free plasma methionine (1). The 
carotids were excised, irrigated with saline, and frozen in liquid nitrogen. 
Previous studies (1) have shown that this synthesis protocol produces a stable 
blood level of [35S]methionine  for at least 5 h. 
SDS-PAGE 
Extracts of  tissue were prepared by dissolving carotids in sample buffer con- 
raining  1% SDS and 1% dithiothreitol (DTT).  These tissue extracts and the 
products of in vivo synthesis, in vitro translation, or cell sorting, were stored 
at -20°C. For SDS-PAGE, these extracts were diluted 1:2 in sample buffer 
containing 1% SDS, 1% DTT,  1 mM phenylmethylsulfonyl  fluoride (PMSF), 
and I mM Na-P-Tosyl-L-arginine  methylester in 0.0625 M Tris-HCI, pH 6.8, 
as previously described (23, 24), and 40 p.g of protein were loaded on 10% 
gels with a  3%  stacking  gel  under reducing conditions (24).  For two- 
dimensional gel electrophoresis, the extracts were diluted  1:5 with buffer 
A according to the method of O'Farrell (30), and between 20 and 50 p.g of 
protein were loaded. The pH gradient was established with 6% preblended 
ampholines, pH 4.0-6.5  (Pharmacia  Fine Chemicals, Lucerne,  Switzer- 
land). The gels were focused at 1,000 V overnight. The second dimension 
was run on 10% polyacrylamide gels. For quantification, the gels of total 
carotid protein extract were stained with Coomassie Blue, and the relative 
proportions of actin isoforms were quantified by densitometry (23). Gels of 
products of in vivo synthesis or in vitro translation were dried and exposed 
to Kodak X-Omat SO-282 film. The relative percentage of actin isoforms 
was determined by densitometry (1, 23). 
Results 
In normal, uninjured carotid arteries the ctSM isoform ac- 
counts for '~80% of the actin protein (Fig.  1; Table I). The 
proportion of ctSM actin mRNA is even greater (90-95 % of 
actin mRNA; Fig. 2). The proportion of ctSM actin synthe- 
Figure  2.  Autoradiogram  of 
Northern  blots  of total  RNA 
(2 p.g/lane) from injured arter- 
ies at 0 h (lane 1 ), 1 h (lane 2), 
8 h (lane 3), 24 h (lane 4), and 
5 d  (lane 5). (A) After hybrid- 
ization with pRAoaA-C (total 
actin probe);  note increase in 
cytoplasmic actin mRNA band 
(2.1 kb) and decrease in a  ac- 
tin band (1.7 kb) at 8  h, 24 h, 
and 5  d.  (B) After hybridiza- 
tion  with  pRAooA-3'UT  (a 
actin probe); note decrease in 
ctSM actin at 8  h  and after. 
sized in vivo or obtained from in vitro translation of total 
RNA is markedly less than that for the proteins (Figs. 3 and 
4; Table II). These results were reported previously for the 
rat aorta (1) and suggest that (a) some of the ctSM messages 
are not translated, and (b) the turnover of the ctSM isoform 
is slower than that of the other actin isoforms. 
Although SMC in injured rat carotid artery start to synthe- 
size DNA between 24 and 27 h after surgery (27), the change 
in actin isoforms from ct to 13 predominance associated with 
proliferation occurred between 1 and 5 d  (Fig.  1; Table I). 
Figure 3.  Autoradiogram of two-dimensional gel electrophoresis of 
total protein extracts from injured or normal carotid arteries of rats 
infused with [3sS]methionine and either saline or heparin, a,  nor- 
mal carotid; b, injured carotid from saline-treated rat at 24 h; c, in- 
jured carotid from heparin-treated rat at 24 h.  Note the decrease 
in a  and increase in [3 actin synthesis in the injured carotids. There 
are  no  significant  differences  between  the  saline-  and  heparin- 
treated injured carotids. To visualize "r actin, the gel in a  has been 
slightly overexposed, thus resulting in some overlapping of a  and 
13 spots. 
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of  Actin mRNA 
Time after injury  ct  13  y 
In vivo synthesis: 
Normal carotid  52.9  ±  1.5  34.9  +  1.9  12.2  ±  0.4 
24 h, saline-treated  31.5  ±  4.3  54.3  ±  4.1  14.1  ±  0.2 
24 h, heparin-treated  37.4  ±  2.0  48.0  ±  1.6  14.6  ±  1.5 
In vitro translation 
0  h  46.9  +  5.2  38.7  +  0.1  14.4  +  5.4 
1 h  43.1  +  2.3  42.3  +  1.2  14.5  +  1.1 
8  h  20.2  +  1.3  65.6  ±  1.3  14.1  ±  1.9 
24  h  21.5  ±  1.3  65.4  ±  1.8  13.1  ±  0.7 
All values are mean (% of total actin) + SD; n =  2 for translation experiments 
and n  =  5 for synthesis experiments.  All values are normalized according to 
the difference in methionine content between ctSM (15 Met) and cytoplasmic 
(16 Met) actins (41). 
Figure 4. Autoradiogram of two-dimensional gel electrophoresis of 
products of in vitro translation of total injured carotid RNA. a, 0 h; 
b, 1 h; c, 8 h; and d, 24 h. Note the change in actin isoforms be- 
tween 1 and 8 h after injury. To visualize "/actin, gels in a and b 
have been overexposed thus resulting in some overlapping of ct and 
13 spots. 
During this period, no changes were observed in the total ac- 
tin content on one-dimensional gels; actin remained between 
12 and 15 % of total protein (data not shown). Nevertheless, 
the relative synthesis of the ¢tSM actin isoform decreased and 
that of the 13 actin isoform increased by 24 h (Fig. 3; Table 
II). Results of in vitro translation experiments (Fig. 4; Table 
II) confirmed the synthesis experiments. Northern blot hy- 
bridization showed that changes in actin isoform synthesis 
and in vitro translation corresponded to variation of the rela- 
tive amounts of ¢tSM and 13 actin  +  ~, actin mRNAs (Fig. 
2; Table III). The change in mRNAs occurred between 1 and 
8 h  (Fig. 2;  Table III). 
To know whether only those SMC committed to enter the 
cell cycle exhibit the change in actin isoform expression, we 
removed the injured carotids at 36 h and sorted SMC into 
G0/G~ and S/G2 populations. The relative proportions of the 
actin isoforms were measured on two-dimensional gels and 
the content of actin mRNA was measured by hybridization 
of Northern blots with the ctSM probe (Fig.  5; Table IV). 
The available evidence supports the view that SMC commit 
to enter the growth cycle shortly after injury and do so as a 
synchronous wave; those cells remaining in the resting state 
do not appear to start proliferating at some later time (7, 8, 
27). Given these special characteristics of SMC hyperplasia 
in the injured carotid and in analogy to previous in vitro ex- 
periments (34), we selected 36 h as a moment when most of 
the cells committed to proliferation would be in S or G2 but 
would not have reached Go/G~ again.  We obtained an S/G2 
population between 20 and  30%  that corresponds closely 
with the measured labeling index and the growth fraction (8, 
27). Two-dimensional gel analysis demonstrated a slight but 
detectable decrease in the proportion of ¢tSM actin in the 
S/G2 cells compared to the G0/Gt  cells (Fig.  5;  Table IV) 
which had an actin isoform pattern identical to that of freshly 
isolated SMC (data not shown). Northern blot hybridization 
demonstrated  that  the  content of aSM  actin  mRNA  was 
lower in S/G2 cells compared to the G0/G, cells (Fig. 5 c). 
To investigate whether the switch in the SMC program of 
actin isoform synthesis was  tightly linked to entry into S 
phase, we inhibited G0/G~-S transition with heparin. Previ- 
ous experiments with the balloon injury model have demon- 
strated that heparin blocks '~50% of the stimulated SMC in 
late Go/G~ and reduces the thymidine labeling index and the 
growth fraction (6, 7, 27). These results were confirmed in 
the present series of experiments and showed that the thymi- 
dine labeling index between 24 and 48 h  was reduced by 
heparin treatment (control: 10.2 +  2.3, n  =  4; heparin:  1.2 
+  0.9, n =  5). However, the change in actin mRNAs and ac- 
tin isoform synthesis (Table II) at 24 h was not prevented by 
a continuous infusion of heparin beginning before the time 
of carotid injury; for both control- and heparin-treated arter- 
ies, ¢tSM mRNA declined by '~50 % and cytoplasmic mRNA 
increased ,'~ twofold (Fig. 6; Table III). At 24 h, the synthesis 
of tlSM actin declined and that of 13 actin increased in injured 
vessels of saline-treated and heparin-treated arteries com- 
pared to normal artery (Fig. 3; Table II). At this time, there 
was no significant difference between the levels of ¢tSM and 
cytoplasmic actins  in  heparin-treated compared to  saline- 
treated arteries. On the other hand, ¢tSM actin mRNA and 
protein were reinduced by 5 d in arteries of heparin-treated 
Table III. Expression of aSM and ~ Actin + ~, Actin mRNAs 
in Normal and Injured Carotid Artery with or without 
Heparin Treatment 
Time after injury  ctSM*  13  +  Y* 
1 h  100  +  2  100  ___  30 
8  h  60  +  26  300  +  130 
24  h  saline  54  ___  21  216  +  22 
24  h  heparin  46  +  12  180  +  62 
5  d  saline  14  +  4  160  +  62 
5  d  heparin  46  +  10  104  +  67 
* Calculated as percentage of the values at 0 h. All values are mean  4-_  SD; 
//  ~  3. 
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Northern  blots  of total RNA 
(2  I~g/lane) from injured  ca- 
rotid  arteries  of saline-  and 
heparin-treated  rats  after  hy- 
bridization  with  pRAo~xA-C 
(A)  or  pRAoaA-3'UT  (B). 
Lane  1,  uninjured  carotid; 
lane  2,  24 h,  saline-treated; 
lane 3, 24 h, heparin-treated; 
lane 4, 5 d, saline-treated; and 
lane  5,  5  d,  heparin-treated. 
Note  decrease  in  ¢t  and  in- 
crease  in  cytoplasmic  actin 
mRNAs  in  both  saline-  and 
heparin-treated carotids at 24 h 
and  a  reinduction  of ct actin 
mRNA at 5 d in the heparin- 
treated carotids. 
Figure 5. Two-dimensional gel electrophoresis  of total protein ex- 
tracts from SMC sorted into Go/Gt (a) and S/G2 (b) populations at 
36 h after injury. In c, an autoradiogram of a Northern blot of total 
RNA (2 ~tg/lane) from GdG1 (les~)  and S/G2 (right) SMC, 36 h af- 
ter endothelial removal, has been hybridized with pRAoaA-3'UT 
(¢tSM probe);  note the  decreased  ¢t  actin  mRNA  band  in  S/G2 
cells compared with G0/G~ cells. 
rats compared to saline-treated rats (Figs.  1 and 6; Tables I 
and III); in heparin-treated arteries, ctSM mRNA increased 
'~ threefold over saline-treated rats, and cytoplasmic mRNAs 
declined slightly (20-50%). 
Discussion 
In the arterial wall of mature animals,  SMC quiescence is 
characterized by a typical pattern of actin isoform expression 
(ct predominance; 20,  31, 41). SMC proliferation is associ- 
ated with a switch to a phenotype similar to that of SMC in 
developing arteries (13 predominance; 20). Proliferating SMC 
show a decrease in smooth muscle-specific contractile pro- 
teins  and an increase in  nonmuscle actin and myosin iso- 
forms (20,  31). Although  it has been  suggested that these 
changes are a prerequisite for proliferation (4), the biochem- 
ical evidence in support of this hypothesis has not been con- 
clusive.  In  primary  culture  of SMC,  ctSM  actin  content 
declines only after the cells have entered S phase (34); ctSM 
actin synthesis decreases before S phase (1) despite the fact 
that  the  relative proportion of ctSM actin mRNA remains 
Table IV. Actin lsoforms in SMC Sorted into Go/Gj and 
S/G2 Populations at 36 h after Carotid Injury 
SMC population  ¢t  13  ~, 
G0/GI  86.1  +  1.0  11.9  +  1.0  2.0  5-  0.5 
S/G2  76.8  +  1.5"  17.2  +  1.5  6.0  5-  0.5 
All values are mean (%  of total actin)  +  SD;  n  =  2. 
* Significantly  different  (p <  0.05  using t test) from values of GdG~  SMC. 
similar to that present in SMC of normal aortic media (21). 
Owens et al. (32) have reported that passaged rat aortic SMC 
growth arrested in serum-free medium synthesize more aSM 
actin  than  when  they  are  proliferating.  When  growth-ar- 
rested SMC are stimulated with serum, ctSM actin synthesis 
decreases before the cells enter S phase. These results sug- 
gest that early after stimulation but before DNA replication, 
ctSM  synthesis  but  not  ctSM  mRNA  and  protein  content 
decreases in cultured rat aortic SMC. A similar observation 
has been made by Wice et al. (43) in the SMC-like cell line 
BC3H1 stimulated by FCS or fibroblast growth factor. How- 
ever Wang and Rubenstein (42) have found in the same cell 
line that epidermal growth  factor inhibits  the  synthesis of 
aSM  actin together with the  expression of its  mRNA.  In 
summary, the in vitro studies of aortic SMC and BC3H1 cells 
suggest that after the addition of mitogen, the repression of 
ctSM actin synthesis can occur at the transcriptional and/or 
translational levels. 
In the present series of experiments, we decided to study 
the changes in SMC actin isoforms with proliferation in vivo 
because of some advantages of the balloon carotid model. 
For example, previous in vivo work has demonstrated that 
aSM actin expression is linked to quiescence (1, 20, 21, 31), 
but in vitro quiescence is difficult to define.  It can be pro- 
duced by withdrawal of serum or by overcrowding and post- 
confluence, but in every instance the actual level of thymi- 
dine  labeling  (1-5%)  is  greater  than  in  vivo  (~0.06%). 
Furthermore, although in normal artery SMC express pre- 
dominantly aSM actin, in vitro quiescent SMC do not (20, 32). 
In addition to being truly quiescent at the outset, SMC in the 
in  vivo arterial  injury  model proliferate as  a  synchronous 
wave.  Proliferation takes place in three dimensions as op- 
posed to two in vitro; this might be of some importance for 
pathological situations.  For these reasons,  we thought that 
the in vivo studies, although more difficult to conduct than 
in vitro ones, would give a clearer picture of how the actin 
isoforms are regulated as SMC enter the growth cycle. 
In the injured rat carotid model of SMC mitogenesis, the 
content of ctSM actin did not decline until 5 d after carotid 
injury, however ctSM actin mRNA levels, ctSM actin synthe- 
sis, and translation of ¢tSM actin mRNA all declined before 
24 h after injury, suggesting the possibility of transcriptional 
Clowes et al.  Smooth Muscle Actin lsoforms and Mitogenesis  1943 or posttranscriptional control. Our in vivo experiments dem- 
onstrated a parallel decline in ¢tSM actin mRNA and newly 
synthesized ctSM actin contrary to what was previously ob- 
served in primary cultures of SMC (21). The decline in ctSM 
actin mRNA corresponded to an increase in 13 and ~' mRNA. 
The increase in 13 actin mRNA and synthesis seems to be a 
general property of not only arterial SMC but also other cells 
entering the growth cycle and might play a central role in the 
regulation of proliferation (11, 16,  17, 25, 43). It is possible, 
however, that the increased expression of the cytoplasmic ac- 
tins is not linked to the down regulation of ctSM actin, since 
Wice et al. (43) found that the addition of fibroblast growth 
factor to quiescent BC3H1 cells does not alter cytoplasmic 
actin synthesis although aSM actin synthesis is decreased. 
The first small but significant changes in the proportion of 
actin isoforms were detected in SMC committed to replicate 
(S/G2)  compared with  cells  remaining  in  Go/G~, and  are 
linked to a clear relative decrease of ¢tSM actin mRNA in 
S/G2 cells. A similar observation has been made previously 
in primary cultured SMC (34). The pattern of actin isoforms 
was clearly modified in the whole population of SMC 5 d af- 
ter endothelial  injury, compared with  the  normal  arterial 
wall. 
From the foregoing it appears that the expression of actin 
isoforms in  SMC undergoing a  change of growth state is 
regulated at multiple levels. A similar situation has been ob- 
served  in  striated  muscle  during  differentiation in  which 
regulation occurs at the translational as well as the transcrip- 
tional and posttranscriptional levels (12). 
Our results demonstrate that in vivo the changes in SMC 
actin  isoform mRNAs  and  synthesis  after endothelial  re- 
moval occur before the cells leave Go/Gt. These changes in 
actin isoform expression might be important for SMC com- 
mitment to cell cycle entry. Alternatively, they might be one 
of the consequences of cell cycle entry. The expression of ac- 
tin isoforms and of their mRNAs  is particularly altered in 
cells entering in the S/G2 phase compared to those remain- 
ing in G0/Gi. 
To test the hypothesis that expression of actin isoforms is 
linked to growth state we measured actin synthesis and the 
le,~els of actin isoform mRNA and protein in injured arteries 
of heparin-treated animals.  We have previously shown that 
heparin inhibits SMC proliferation in injured rat carotid ar- 
tery by blocking the transition from G0/G~ to S phase but 
does not suppress the expression of ornithine decarboxylase, 
an  activity  characteristic  of early  G~  (27).  Similar  find- 
ings have been made in vitro (2). We designed the experi- 
ments to answer two questions: (a) does heparin inhibit the 
program of actin isoform changes induced in injured artery, 
and (b) does it cause the early reinduction of the quiescent 
phenotype (¢tSM  actin predominance) in association with 
growth  inhibition?  Our  results  demonstrate that  although 
growth of SMC is inhibited by heparin, the Ge/Gt changes 
in actin isoform mRNAs and synthesis are not prevented. On 
the other hand,  by keeping a  large fraction of the carotid 
SMC in the resting state with heparin treatment, we observed 
a re-expression of ¢tSM actin mRNA and protein at a time 
after injury (5 d) when cytoplasmic actin mRNAs and protein 
are usually predominant. Expression of the quiescent pheno- 
type is not observed under normal circumstances until 60 d 
after injury (20). 
These results suggest that a switch from predominance of 
ctSM to predominance of 13 and ), actin mRNAs and synthesis 
is an early change affecting the SMC after endothelial injury. 
It may be necessary but certainly is not sufficient for entry 
of SMC into the replicative state. Heparin does not affect the 
early change in actin isoform mRNAs and synthesis even 
though it does inhibit Go/G~ to S transition.  Our findings 
are somewhat analogous, in a reverse sense, to what has been 
described in striated muscle cells stimulated to undergo fu- 
sion but blocked by various pharmacological agents (12); un- 
der some circumstances expression of muscle-specific  mRNAs 
as well as fusion are inhibited while under others the muscle- 
specific mRNAs are still expressed despite the lack of fusion. 
The  finding  that  aSM  actin  is  expressed  by  heparin- 
inhibited  SMC  suggests  the  possibility  that  the  heparin- 
inhibited state might closely resemble true quiescence. This 
hypothesis has been proposed by several groups and is sup- 
ported by the observation that heparin and heparan sulfate 
extracted from normal arteries or by cultured endothelium 
and quiescent SMC inhibit SMC growth and migration in 
vitro (2,  3,  13, 26,  27).  In other organ systems heparin or 
heparin-like molecules promote functions characteristic of 
the differentiated state (36).  These observations also  sup- 
port the possibility that quiescence in a normal artery is ac- 
tively  maintained.  Alternatively,  increased  expression  of 
ctSM actin might be part of any program that keeps SMC 
from proliferating. The relationship between quiescence in 
a normal artery and the growth-inhibited state produced by 
heparin in an injured artery will be clarified when the pat- 
terns of expression of the actin isoforms and other muscle- 
specific proteins have been defined under a variety of condi- 
tions of growth arrest. 
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